Efficacy of Corneal Cross-Linking (CXL) in the Treatment of Pediatric Keratoconus

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

April 2, 2024

Primary Completion Date

May 2, 2025

Study Completion Date

July 1, 2025

Conditions
Keratoconus
Interventions
PROCEDURE

Crosslinking

Corneal Cross-Linking (CXL) is a minimally invasive procedure used to strengthen the cornea by increasing the chemical bonds between collagen fibers. It is primarily used to treat keratoconus and corneal ectasia, conditions where the cornea becomes progressively thinner and weaker.

Trial Locations (2)

34517

Ehab tharwat, Damietta

Unknown

Al-Azhar university, Damietta

All Listed Sponsors
lead

Al-Azhar University

OTHER

NCT07080983 - Efficacy of Corneal Cross-Linking (CXL) in the Treatment of Pediatric Keratoconus | Biotech Hunter | Biotech Hunter